Structure-activity relationships of histamine H2 receptor ligands

被引：31
|
作者：
Dove, S
Elz, S
Seifert, R
Buschauer, A [1 ]
机构：
[1] Univ Regensburg, Inst Pharm, D-93040 Regensburg, Germany
[2] Univ Kansas, Dept Pharmacol & Toxicol, Lawrence, KS 66045 USA
来源：
MINI-REVIEWS IN MEDICINAL CHEMISTRY | 2004年 / 4卷 / 09期
关键词：
H-2 receptor agonists; H-2 receptor antagonists; impromidine analogues; arpromidine; molecular modelling; structure-activity relationships; QSAR; site-directed mutagenesis;
D O I：
10.2174/1389557043403242
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Recent research on histamine H-2 receptor agonists was focused on quantitative structure-activity relationships and receptor models explaining the activity of imidazolylpropylguanidines. Their selectivity for guinea pig vs. human isoforms was investigated using H-2 receptor-G(salpha) fusion proteins and attributed to amino acid differences in transmembrane domains 1 and 7. New antagonists result from approaches to improve pharmacokinetic properties and to design hybrid drugs which additionally have gastroprotective or anti H. pylori activity.
引用
收藏
页码：941 / 954
页数：14
相关论文
共 50 条
  • [21] Design, synthesis, and structure-activity relationships of acetylene-based histamine H3 receptor antagonists
    Ali, SM
    Tedford, CE
    Gregory, R
    Handley, MK
    Yates, SL
    Hirth, WW
    Phillips, JG
    JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (05) : 903 - 909
  • [22] Structure-Activity Relationships of hNPFF2 Receptor
    Rathmann, Rd
    JOURNAL OF PEPTIDE SCIENCE, 2010, 16 : 166 - 167
  • [23] Structure-Activity Relationships of Butyrophilin 3 Ligands
    Wiemer, Andrew J.
    CHEMMEDCHEM, 2020, 15 (12) : 1030 - 1039
  • [24] STRUCTURE-ACTIVITY RELATIONSHIP IN HISTAMINE H-2-RECEPTORS
    ENRIZ, RD
    CIUFFO, GM
    ESTRADA, MR
    JAUREGUI, EA
    ARCHIVOS DE BIOLOGIA Y MEDICINA EXPERIMENTALES, 1986, 19 (02): : R201 - R201
  • [25] Synthesis and structure-activity relationships of potent retinoid X receptor ligands.
    Jeong, S
    Farmer, LJ
    CananKoch, SS
    Nadzan, AM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 66 - MEDI
  • [26] Synthesis and structure-activity relationships of aminoalkylazetidines as ORL1 receptor ligands
    Wu, WL
    Caplen, MA
    Domalski, MS
    Zhang, HT
    Fawzi, A
    Burnett, DA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (21) : 3157 - 3160
  • [27] Three-dimensional quantitative structure-activity relationships for androgen receptor ligands
    Waller, CL
    Juma, BW
    Gray, LE
    Kelce, WR
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1996, 137 (02) : 219 - 227
  • [28] Validation of a histamine H3 receptor model through structure-activity relationships for classical H3 antagonists
    Lorenzi, S
    Mor, M
    Bordi, F
    Rivara, S
    Rivara, M
    Morini, G
    Bertoni, S
    Ballabeni, V
    Barocelli, E
    Plazzi, PV
    BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (19) : 5647 - 5657
  • [29] Novel histamine H-3-receptor antagonists with benzyl ether structure or related moieties: Synthesis and structure-activity relationships
    Huls, A
    Purand, K
    Stark, H
    Reidemeister, S
    Ligneau, X
    Arrang, JM
    Schwartz, JC
    Schunack, W
    ARCHIV DER PHARMAZIE, 1996, 329 (8-9) : 379 - 385
  • [30] HISTAMINE H2 RECEPTOR ANTAGONISTS
    DIPALMA, JR
    AMERICAN FAMILY PHYSICIAN, 1974, 10 (06) : 140 - 142
12345